The authors undertook qualitative interviews with 209 injecting drug users in three Russian cities to explore IDU's accounts of HIV and health risk. Policing practices, and how these violate health and human rights, emerged as a primary theme.
This book gathers the presentations given during the V and VI National Conferences on Drug Policy in Buenos Aires and aims to identify policies that protect public health and human rights. Published by Intercambios Civil Association and the School of Social Sciences of Buenos Aires University.
In an effort to make drug policy publications accessible to a wider audience, the Open Society Institute's Global Drug Policy Program (GDPp) has decided to select five article and have them translated into Chinese, Farsi, French and Russian.
This IHRA Report exposes the links between the carrying out of executions and the financial contributions from European governments, the European Commission and the UNODC to support drug enforcement operations in countries that use the death penalty.
The purpose of this report is to examine and evaluate this mechanism for law reform, without the need for legislative reform, and to consider the specific discussion around sentencing for drug offences which it has led to.
Global drug use is shifting from heroin and cocaine towards synthetic drugs, the UN said, also noting a growing demand for illicit substances in developing countries.
The 2010 World Drug Report shows a shift towards new drugs and new markets. There are signs of an increase in drug use in developing countries, and a growing abuse of ATS and prescription drugs around the world
This second TNI-BCN briefing 'Burma's 2010 Elections: Challenges and Opportunities' provides an overview of the more significant challenges and opportunities, discusses the political dynamics in the lead up to the polls, and suggests some post-election scenarios.
A joint Transnational Institute (TNI) and Burma Centrum Netherlands (BCN) initiative today releases its first Burma Policy Briefing on ethnic conflict.
As the second major report in the series, the document provides a region-by-region update of key developments in harm reduction, as well as several issues key to the response to drug-related harms worldwide.